Clinical Care and Research Propel Nephrology Division
When Jochen Reiser, M.D., Ph.D., the Peggy and Harold Katz Professor of Medicine and vice chair for research in the Department of Medicine, joined the Miller School four years ago as chief of the Division of Nephrology and Hypertension, the division boasted an excellent clinical program with a strong focus on kidney transplantation.
Miller School Study Identifies Master Regulator for Schizophrenia
A team of researchers led by Claes Wahlestedt, M.D., Ph.D., the Miller School’s associate dean for therapeutic innovation, has pinpointed a “master” regulatory molecule in the brain that is altered in people with schizophrenia. The finding could facilitate the development of better drugs for the debilitating psychiatric disorder that affects an estimated one percent of the world’s population.
Stimulation of GHRH Action May Improve Pneumonia Survival
Miller School scientists are part of an international research team that may have found a way to block a second wave of death that can result from pneumonia treatment.
Bascom Palmer Marks 50 Years with Major Expansion Plans, Global Research Initiatives
Just in time to celebrate its 50th anniversary, Bascom Palmer Eye Institute Chairman Eduardo C. Alfonso, M.D., has announced plans to significantly expand clinical care and research at all four of its facilities across South Florida.
UM Study Finds Possible Link Between Diet Soda and Vascular Risks
People who drink diet soft drinks on a daily basis may be at increased risk of suffering vascular events such as stroke, heart attack, and vascular death, according to a new study led by Hannah Gardener, Sc.D., epidemiologist in the Miller School’s Department of Neurology.